YANG Ge, JIANG Yan, LI Jun, et al. Effect of Compound Danshen Dropping Pills in Interfering Apoptosis-related Genes of Coronary Heart Disease with Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(20): 153-157.
DOI:
YANG Ge, JIANG Yan, LI Jun, et al. Effect of Compound Danshen Dropping Pills in Interfering Apoptosis-related Genes of Coronary Heart Disease with Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(20): 153-157. DOI: 10.13422/j.cnki.syfjx.2016200153.
Effect of Compound Danshen Dropping Pills in Interfering Apoptosis-related Genes of Coronary Heart Disease with Blood Stasis Syndrome
目的:研究复方丹参滴丸干预冠心病血瘀证凋亡相关基因,寻找复方丹参滴丸干预CHD血瘀证的有效靶点。方法:通过中西医结合病证临床研究,用逆转录-聚合酶链反应(RT-PCR)方法,观察常规治疗对照组治疗前后和复方丹参滴丸治疗组治疗前后凋亡相关基因的变化。结果:治疗组治疗后B淋巴细胞瘤-2(Bcl-2)Associated Transcription Factor1(BCLF1)mRNA表达显著降低(P<0.01),凋亡相关基因(Bcl-2 assaciated X protein,Bax)mRNA表达有降低趋势,两组治疗前后Bcl-2和凋亡信号转导分子(Cysteine asparate specific protease-3,Caspase-3)mRNA表达无明显差异。结论:复方丹参滴丸治疗后冠心病血瘀证患者相关基因凋亡相关转录因子BCLF1 mRNA表达显著减弱,凋亡相关基因Bax mRNA表达受到抑制,复方丹参滴丸可能通过调控细胞凋亡相关基因的表达,对冠心病血瘀证患者发挥治疗保护作用。
Abstract
Objective: In previous studies
we had screened and verified the relevant genes of coronary heart disease(CHD) with syndrome of blood stasis (SBS). Relevant genes of CHD with SBS were studied to reveal the pathobiology
and discover effective targets of DSP (compound Danshen dropping pills) in interfering CHD with SBS. Method: Reverse transcription-PCR was used to study the effect of DSP in interfering relevant genes and its clinic effect on CHD with SBS. Result: After treatment with DSP
the mRNA expression of BCLF1 (Bcl-2 associated transcription factor 1) decreased obviously(P<0.01)
and the mRNA expression of Bax (Bcl-2 assaciated X protein) showed a downward trend. But the mRNA expressions of Bcl-2 (B cell lymphoma/lewkmia-2) and Caspase-3 (cysteine asparate specific protease-3) had no difference before and after the treatment. Conclusion: The study proves that DSP can significantly reduce the mRNA expression of BCLF1 of relevant genes of CHD with SBS
and inhibit the mRNA expression of Bax. It treats CHD with SBS by regulating expressions of apoptosis-related genes of coronary heart disease with blood stasis syndrome.